1. Home
  2. PULM vs DFLI Comparison

PULM vs DFLI Comparison

Compare PULM & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • DFLI
  • Stock Information
  • Founded
  • PULM 2003
  • DFLI 2020
  • Country
  • PULM United States
  • DFLI United States
  • Employees
  • PULM N/A
  • DFLI N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • PULM Health Care
  • DFLI Technology
  • Exchange
  • PULM Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • PULM 21.0M
  • DFLI 15.2M
  • IPO Year
  • PULM N/A
  • DFLI N/A
  • Fundamental
  • Price
  • PULM $7.10
  • DFLI $2.28
  • Analyst Decision
  • PULM
  • DFLI Strong Buy
  • Analyst Count
  • PULM 0
  • DFLI 5
  • Target Price
  • PULM N/A
  • DFLI $15.66
  • AVG Volume (30 Days)
  • PULM 37.6K
  • DFLI 71.2K
  • Earning Date
  • PULM 03-27-2025
  • DFLI 11-14-2024
  • Dividend Yield
  • PULM N/A
  • DFLI N/A
  • EPS Growth
  • PULM N/A
  • DFLI N/A
  • EPS
  • PULM N/A
  • DFLI N/A
  • Revenue
  • PULM $10,005,000.00
  • DFLI $48,871,000.00
  • Revenue This Year
  • PULM N/A
  • DFLI N/A
  • Revenue Next Year
  • PULM $1.00
  • DFLI $50.98
  • P/E Ratio
  • PULM N/A
  • DFLI N/A
  • Revenue Growth
  • PULM 47.05
  • DFLI N/A
  • 52 Week Low
  • PULM $1.55
  • DFLI $2.50
  • 52 Week High
  • PULM $8.44
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • PULM 62.30
  • DFLI 38.83
  • Support Level
  • PULM $6.84
  • DFLI $2.16
  • Resistance Level
  • PULM $8.14
  • DFLI $2.62
  • Average True Range (ATR)
  • PULM 0.39
  • DFLI 0.27
  • MACD
  • PULM 0.11
  • DFLI 0.00
  • Stochastic Oscillator
  • PULM 71.43
  • DFLI 16.67

About PULM Pulmatrix Inc.

Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: